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Abstract
Crumbs family proteins are apical transmembrane proteins with ancient roles in cell polarity.
Mouse Crumbs2mutants arrest at midgestation with abnormal neural plate morphology
and a deficit of mesoderm caused by defects in gastrulation. We identified an ENU-induced
mutation, wsnp, that phenocopies the Crumbs2 null phenotype. We show thatwsnp is a
null allele of Protein O-glucosyltransferase 1 (Poglut1), which encodes an enzyme previ-
ously shown to add O-glucose to EGF repeats in the extracellular domain of Drosophila and
mammalian Notch, but the role of POGLUT1 in mammalian gastrulation has not been inves-
tigated. As predicted, we find that POGLUT1 is essential for Notch signaling in the early
mouse embryo. However, the loss of mouse POGLUT1 causes an earlier and more dra-
matic phenotype than does the loss of activity of the Notch pathway, indicating that
POGLUT1 has additional biologically relevant substrates. Using mass spectrometry, we
show that POGLUT1 modifies EGF repeats in the extracellular domain of full-length mouse
CRUMBS2. CRUMBS2 that lacks the O-glucose modification fails to be enriched on the api-
cal plasma membrane and instead accumulates in the endoplasmic reticulum. The data
demonstrate that CRUMBS2 is the target of POGLUT1 for the gastrulation epithelial-to-
mesenchymal transitions (EMT) and that all activity of CRUMBS2 depends on modification
by POGLUT1. Mutations in human POGLUT1 cause Dowling-Degos Disease, POGLUT1 is
overexpressed in a variety of tumor cells, and mutations in the EGF repeats of human
CRUMBS proteins are associated with human congenital nephrosis, retinitis pigmentosa
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and retinal degeneration, suggesting that O-glucosylation of CRUMBS proteins has broad
roles in human health.
Author Summary
Post-translational addition of sugar chains is essential for normal activity of many secreted
and transmembrane proteins and dozens of human genetic diseases are associated with
congenital disorders of glycosylation. Protein O-glucosyltransferase 1 (POGLUT1), which
is essential for early mouse development, catalyzes the addition of O-glucose to extracellu-
lar EGF repeats of proteins, including NOTCH1. Here we show that mouse POGLUT1
modifies NOTCH1 in vivo; however, the essential role of POGLUT1 in gastrulation is due
to POGLUT1-dependent glycosylation of EGF repeats in the apical polarity protein
CRUMBS2. In contrast to findings in Drosophila, where modification of Crumbs by
POGLUT1 is not required, mouse POGLUT1 is required for the activity of CRUMBS2: the
unmodified protein fails to localize to the apical membrane and the gastrulation defects of
Poglut1mutants are indistinguishable from those of Crumbs2mutants. Human mutations
in POGLUT1 cause Dowling-Degos Disease type 4; the hyperpigmentation associated with
this autosomal dominant disease was previously attributed to altered Notch signaling, but
our results suggest that this disease and other POGLUT1-associated phenotypes may be
due to altered activity of CRUMBS proteins.
Introduction
Glycosylation can regulate protein stability and function by ensuring efficient protein folding
and by altering the binding affinity to interacting partners [1–7]. The biological importance of
this type of protein modification is highlighted by dozens of human diseases caused by congen-
ital disorders of glycosylation (CDGs), which are categorized based the chemical linkage, the
added sugar, and the enzymes mutated in affected individuals [8–10]. Developmental defects
in mice with mutations in glycosyltransferases have defined specific developmental roles for
protein glycosylation in FGF and Notch signaling and in the composition of the extracellular
matrix [11–18].
Epidermal Growth Factor (EGF) repeats are cysteine-containing motifs of about 40 amino
acids found in many transmembrane and secreted proteins, including the Crumbs proteins
and members of the Notch family receptors and ligands. EGF repeats can mediate ligand-
receptor interactions and facilitate protein folding, and these interactions can be modified by
glycosylation [4, 5]. EGF repeats can be modified by three types of O-linked glycosylation:
O-fucosylation, O-GlcNAcylation and O-glucosylation. O-Fucose is added to the serine or
threonine in the consensus C2-X-X-X-X-(S/T)-C3 (where Cx refers to the conserved cysteines
in the EGF repeats) [19], O-GlcNAc to the serine or threonine in the putative consensus
C5XXGX(S/T)GXXC6 [20] and O-glucose to the serine in the consensus sequence C1-X-S-X-
(P/A)-C2 [21]. Specific enzymes add these sugars to EGF repeats: Protein O-fucosyltransferase
1 (POFUT1) [22], EGF-specific O-GlcNAc transferase (EOGT) [23] and Protein O-glucosyl-
transferase 1 (POGLUT1) [24], respectively. POFUT1 and POGLUT1 are essential for develop-
ment in both Drosophila and mammals [13, 24–26].
POGLUT1 (also called KTELC1 or human CAP10-like protein 46KD (hCLP46) [27, 28]) is
the only mammalian enzyme known to add O-glucose to the EGF repeats of NOTCH [24].
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Drosophila Poglut1 (Rumi) was identified in a genetic screen based on its role in Notch signal-
ing and was shown to modify the EGF repeats on the extracellular domain of Notch receptor.
Rumimutants have a temperature dependent defect in Notch signaling: at high temperature,
the Notch receptor is not cleaved after binding to its ligand, preventing formation of the active
Notch intracellular domain (NICD), whereas Notch proteolysis is normal at low temperature.
O-glucosylation does not appear to affect ligand binding, and the data suggest it is required to
couple binding of ligand to proteolytic activation of the receptor [24]. Mammalian POGLUT1
was identified based on homology to the Drosophila protein and was also shown to have O-glu-
cosyltransferase activity [13, 29]. Inactivation of mouse Poglut1 causes midgestation lethality
with defects in neural tube development, somitogenesis, cardiogenesis, and vascular remodel-
ing [13]. Knockdown of mouse Poglut1 decreases Notch signaling in C2C12 cells, but does not
strongly affect the levels of cell surface Notch protein or the binding of NOTCH to its ligand;
instead, like the Drosophila protein, POGLUT1-dependent modification appears to affect
mouse Notch activity at a step between ligand binding and S3 cleavage of NOTCH [13]. A
number of other proteins contain predicted sites of POGLUT1 modification [13], including
Drosophila Crumbs and mammalian CRUMBS1 and CRUMBS2.
Crumbs family proteins have essential, evolutionarily conserved roles in the organization
and integrity of epithelia. Mammals have three members of the Crumbs family (CRUMBS1,
CRUMBS2 and CRUMBS3). CRUMBS1 and CRUMBS2 have large extracellular domains that
include multiple EGF-like repeats, and CRUMBS3 is a short membrane-anchored protein that
includes the conserved cytoplasmic domain. Humans and mice that lack Crumbs1 are viable
but experience light-dependent retinal degeneration [30]. Mice lacking Crumbs3 die shortly
after birth due to defects in lung and intestinal epithelia [31]. Mouse Crumbs2mutants arrest
at mid-gestation with a variety of morphological defects that have been attributed to a defective
polarity in the epiblast [32].
We isolated an ENU-induced mutation called wsnp (wing-shaped neural plate) based on its
striking abnormal morphology at midgestation, including a deficit of mesoderm and a
completely open neural plate [33]. Here we show that wsnp is a null allele of Poglut1 and that
Notch signaling is almost completely blocked in Poglut1wsnp embryos in vivo. However, the
phenotype of Poglut1wsnp and Poglut1-/- mutant embryos is more severe than the phenotype
caused by complete loss of Notch signaling, suggesting that POGLUT1 has additional targets
during mouse embryonic development. We noted that the early phenotype of Poglut1mutant
embryos was similar to that described for Crumbs2 [32] and strongly resembled that of another
ENU-induced mutant characterized in the gene encoding Erythrocyte protein band 4.1l5
(Epb4.1l5), which can interact with the intracellular domain of Crumbs proteins [34–36]. Here
we show that CRUMBS2 must be O-glucosylated by POGLUT1 for its activity during the
mammalian gastrulation epithelial-to-mesenchymal transition (EMT). In the absence of
POGLUT1, CRUMBS2 is trapped in the endoplasmic reticulum and is not trafficked to the api-
cal plasma membrane. The data show that this trafficking defect causes a complete loss of
CRUMBS2 function and argue that the loss of apical CRUMBS2 is responsible for the gastrula-
tion defects seen in Poglut1 null embryos.
Results
An ENU-induced null allele of Poglut1 causes midgestation lethality with
characteristic morphological defects
We isolated the wing-shaped neural plate (wsnp) mutant in a screen for ENU (N-ethyl N-
nitrosourea)-induced recessive mutations that disrupt the morphology of the mid-gestation
embryo [33, 37]. The mutants at E8.5 had a shortened anterior-posterior body axis, lacked
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Pax3+ somites (Fig 1A) and had a flat SOX2+ neural epithelium that failed to close and form a
neural tube (Fig 1B). Sonic hedgehog (Shh) is expressed along the midline notochordal plate of
wild-type E8.5 embryos, whereas wsnpmutants had discontinuous patches of midline Shh
expression, demonstrating a disruption in specification or morphogenesis of the mesendoderm
(Fig 1C). Despite the reduction in mesoderm-derived tissues in wsnpmutants, they formed a
single primitive streak on the posterior side of the embryo, as seen by markers of Nodal and
Wnt signaling (S1 Fig).
We mapped wsnp to a 407 kb interval between the D16Mit90 and D16Mit12 SSLP markers.
Exonic sequences in this interval were captured and SOLiD sequencing identified a single
nucleotide substitution in the interval (see Methods), a T to C transition in the splice donor site
of intron 3 of Poglut1, an endoplasmic reticulum resident enzyme that adds O-glucose to EGF
repeats of proteins [24]. The wsnpmutation resulted in abnormally spliced products that
Fig 1. wsnp is a null allele of Poglut1. (A) Pax3 is expressed in the dorsal neural tube and somites of WT E8.5 embryos. Neural tube closure fails inwsnp
mutants, leading to the widely separated stripes of Pax3 expression; no somite expression of Pax3 is detected in the mutants. (B) Immunostaining for SOX2
expression in transverse sections of E8.5 neural epithelia. While the wild-type neural tube at trunk level is closed, thewsnp neural epithelium remains flat and
fails to close. (C) Sonic hedgehog (Shh) expression at E8.5, showing a continuous midline in WT embryos and a discontinuous midline inwsnpmutants. (D)
The Poglut1 protein includes a signal peptide, a CAP10 domain and an endoplasmic reticulum retention signal (KTEL). Thewsnp allele harbors a splice site
mutation that leads to multiple spliced products (either including a part of the intron 3 or skipping exon3), which both disrupt the enzymatic domain. Exon 4 is
deleted in the Poglut1 Δ allele leading to a frameshift and a premature stop codon. The line for the Poglut1Δ allele indicates where the wild-type protein
sequence stops. (E)Meox1 is expressed in the E8.5 paraxial mesoderm, which is segmented in WT, but not inwsnp homozygotes or in Poglut1 Δ/wsnp
transheterozygous embryos, demonstrating thatwsnp fails to complement Poglut1 Δ. (A, C, E) Dorsal views, anterior up. Scale bars = 150 μm.
doi:10.1371/journal.pgen.1005551.g001
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lacked most of the CAP10 catalytic domain and the KTEL ER-retention signal, and was there-
fore likely to be a strong loss-of-function allele (Fig 1D). We generated a null allele of the gene
from embryonic stem cells from the International Mouse Knockout Project (Poglut1 Δ; Materi-
als and Methods). Poglut1wsnp/Δ embryos showed the same midgestation lethality and abnormal
morphology seen in wsnp/wsnp and Poglut1Δ /Poglut1Δ embryos, demonstrating that wsnp was
a null allele of Poglut1 (Fig 1E). The embryonic phenotype of the wsnp and Poglut1 Δ/Δ homo-
zygotes resembled that reported previously for a gene trap allele of the gene [13].
Because of its ubiquitous expression in the embryo (S2A Fig), we tested whether POGLUT1
activity was required in the epiblast-derived or extraembryonic tissues of the embryo. We gen-
erated embryos in which Poglut1 was deleted specifically in the epiblast using the conditional
allele derived from the International Mouse Knockout Project allele and the Sox2-Cre trans-
gene [38]. Poglut1 epiblast-deleted embryos died before E9.0 and were indistinguishable from
wsnpmutants, with reduced and unsegmented paraxial mesoderm and a flat neural plate (S2C
Fig). Thus, POGLUT1 activity is required in the embryonic tissues for normal development.
POGLUT1 is required for Notch signaling in the mouse in vivo
Knockdown of Poglut1 in mammalian cell lines decreases Notch signaling [13] but a direct
effect of POGLUT1 on Notch signaling has not been studied in an in vivo context. To deter-
mine whether Notch signaling was altered in Poglut1wsnp embryos, we tested whether NOTCH
was correctly processed to form NICD, the active transcription factor form of the protein. In
wild-type E8.5 embryos, most of the Notch protein was active, as assayed by the presence of
active NOTCH1 in whole embryo lysates probed with the antibody that specifically recognizes
the U-secretase cleaved (S3 cleaved, Val1744) active NOTCH1 [39] (Fig 2A). The amount of
NICD was greatly reduced (6.9 ± 1.3 fold) in Poglut1wsnp mutants (Fig 2A). In parallel, an anti-
body to the intracellular domain that detects both full-length and active NOTCH1 confirmed
that active NOTCH1 was decreased in Poglut1wsnp mutants, while the full-length unprocessed
form was more abundant in Poglut1wsnp embryos than in wild type (Fig 2A).
By immunostaining, NICD was detected around the node (Fig 2B) and in the nascent meso-
derm cells emerging from the primitive streak in wild-type embryos (Fig 2C), similar to previ-
ous findings [40]. Active NOTCH1 was greatly reduced in Poglut1wsnp mutants by this assay, in
either the distal view or in sections through the primitive streak (Fig 2B and 2C). Consistent
with the lack of active NOTCH1 protein, the expression of direct transcriptional targets of the
Notch pathway, Hes5, Lunatic Fringe and Hes7, was strongly reduced in Poglut1wsnp mutants
compared to wild type at E8.5 (Fig 2D–2F).
CRUMBS2 as a target of POGLUT1
Although the data show that POGLUT1 is required for normal Notch signaling in the mouse
embryo, the phenotypes of Poglut1mutant embryos were more severe than the phenotypes of
Notch pathway mutants. Mammals have four Notch proteins and multiple ligands, and com-
pound mutants lacking all of the receptors have not been analyzed. However, mammals have
only a single gene encoding the essential transcriptional NICD co-factor Rbpjk and two Prese-
nilin genes that can cleave Notch proteins to their active form. Rbpjkmutants and Presenilin
double mutants differentiate mesoderm-derived structures, including somites, and close their
neural tubes [41, 42], unlike Poglut1wsnp embryos. Thus POGLUT1 appears to have additional,
Notch-independent activities in the early mouse embryo.
In addition to the Notch family of receptors and ligands, over 40 proteins in the mouse
genome contain predicted POGLUT1 modification sites [13]. Among these proteins,
CRUMBS1 and CRUMBS2 have extracellular EGF repeats that could be modified by
POGLUT1 Is Required for Activity of Mouse CRUMBS2
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POGLUT1 (Fig 3A), and the Crumbs2-/- embryonic phenotype appeared to be similar to
that of Poglut1mutants [32], making it a good candidate for a POGLUT1 target. Indeed,
recent studies showed that Drosophila Crumbs can be modified by addition of O-glucose,
although that modification is not required for the function of Drosophila Crumbs [43]. Consis-
tent with a difference in post-translational modification, we found that CRUMBS2 protein
from Poglut1wsnp mutant embryonic extracts at E8.5 migrated more rapidly than CRUMBS2
protein from wild-type embryos (Fig 3B).
Fig 2. POGLUT1 is required for mammalian Notch signaling in vivo. (A) Western blots of wild type and Poglut1wsnp E8.5 embryonic lysates probed with
antibodies for NOTCH1. Upper panel, an antibody that recognizes the intracellular domain of NOTCH1 shows the reduction of cleaved NOTCH1 in
Poglut1wsnpmutants. In the lower panel, the Val1744 antibody that recognizes the active NOTCH1, shows the reduction of the active form in Poglut1wsnp
mutants. α-TUBULIN is the loading control. (B) Whole mount immunostaining for active NOTCH1 at E7.75. View from the distal tip of the embryo (extended
projection), anterior to the left, shows active NOTCH1 expression around the node (asterisk) in wild-type embryos, which is absent in Poglut1wsnpmutants.
(C) Single optical transverse section through the primitive streak (to the right), showing active NOTCH1 expression in the nascent mesoderm in wild-type
embryo and its reduction in Poglut1wsnpmutants. (D-F) Expression of the Notch pathway targetsHes5 (D), Lunatic Fringe (E) andHes7 (F) in E8.5 wild-type
and Poglut1wsnp embryos. (E, F) are dorsal views, anterior up. (D) is a ventral view with anterior up. Scale bars: 42 μm in B, C and 150 μm in D, E and F.
doi:10.1371/journal.pgen.1005551.g002
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Fig 3. EGF repeat 6 in the purified full-length CRUMBS2 protein is O-glucosylated. (A) The domain organization of mammalian CRUMBS proteins. All
three proteins have a short highly conserved cytoplasmic domain and a large variable extracellular domain. CRUMBS1 has 19 EGF repeats, 13 of which could
bemodified by POGLUT1, and CRUMBS2 has 15 EGF repeats, 8 of which could bemodified by POGLUT1 based on its consensus recognition sequence [13,
48]. (B) Western blot of wild-type, Poglut1wsnp andCrumbs2-/- E8.5 embryos probed with a pan-CRUMBS antibody, showing the more rapid migration of
CRUMBS2 in Poglut1wsnp embryos and the absence of this band inCrumbs2mutants. (C) Western blot for expression of endogenous CRUMBS2 in embryoid
bodies at day 6 following differentiation from ES cells probed with pan-CRUMBS antibody. As in embryos, CRUMBS2 inPoglut1wsnp embryoid bodiesmigrated
more rapidly than the protein in wild-type embryos. (D-E) Mass spectral analysis of O-glucosylation of full-length tagged CRUMBS2 purified fromWT and
Poglut1wsnp EBs differentiated for 2 days. Relative amounts of different glycoforms of the peptide 258SGERCEVDEDECASGPCQNGGQCL281 from EGF repeat
6 of CRUMBS2 were compared by generating Extracted Ion Chromatograms (EICs) from the mass spectral data. (D) The peptide from wild-type EBs was
modified with O-glucose in the trisaccharide form (green line). The same peptide fromPoglut1wsnpEBs (E) was unmodified by O-glucose (black line). Glucose is
represented by a blue circle, xylose by a yellow star, and the peptide by a black line. Full mass spectra for the peptides from each sample are shown in S3B and
S3C Fig.
doi:10.1371/journal.pgen.1005551.g003
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The extracellular domain of full-length CRUMBS2 is modified directly by
POGLUT1 in vivo
To analyze whether CRUMBS2 was a direct target of POGLUT1 in vivo, we needed to purify
microgram amounts of CRUMBS2 protein from wild type and mutants. We therefore gener-
ated wild-type and Poglut1wsnp mutant embryonic stem cells (ES cells) from mouse blastocysts
under 2i+LIF conditions [44] and expressed full-length CRUMBS2 with a V5-tag in these cells.
ES cells are not epithelial and therefore did not express high levels of endogenous CRUMBS2.
After differentiation, wild-type embryoid bodies (EBs) at day 6, which is equivalent to E8.5 of
mouse gestation, expressed endogenous CRUMBS2 (Fig 3C). EBs derived from Poglut1wsnp
mutant ES cells also expressed endogenous CRUMBS2, but it migrated more rapidly than the
protein derived from wild-type embryoid bodies (Fig 3C), as seen in embryos (Fig 3B). We
therefore used wild-type and Poglut1wsnp EBs for biochemical analysis.
We purified the full-length V5-tagged CRUMBS2 from wild-type and mutant EBs (S3A
Fig), and subjected the proteins to chymotrypic digestion and analyzed by nanoLC-MS/MS as
previously described [45]. Analysis of a peptide derived from EGF repeat 6 of CRUMBS2 puri-
fied from wild-type embryoid bodies showed that it was modified by the addition of an O-glu-
cose trisaccharide, in which the O-glucose was elongated by the addition of two xylose residues
(Fig 3D; S3B Fig). This trisaccharide glycoform is also found on the EGF repeats of mammalian
NOTCH1 containing the POGLUT1 consensus sequence for O-glucosylation [13, 21, 46]. This
sugar modification was absent in EGF repeat 6 of CRUMBS2 purified from Poglut1wsnp embry-
oid bodies. Instead, the unmodified peptide was the only species detectable in the Poglut1wsnp
mutants (Fig 3E; S3C Fig). These data demonstrate that EGF repeat 6 in the extracellular
domain of the full-length CRUMBS2 protein was O-glucosylated by POGLUT1 in vivo.
POGLUT1 is required for cell surface localization of CRUMBS2
The observed difference in migration on SDS-PAGE between CRUMBS2 protein from
Poglut1wsnp and wild-type embryos and embryoid bodies (Fig 3B and 3C) was greater than
could be accounted for simply by loss of O-glycosylation and suggested that there might be dif-
ferences in N-glycosylation that takes place in the ER and the Golgi. To test this, we treated the
CRUMBS2 protein purified from embryoid bodies with Endoglycosidase H (Endo H) or Pep-
tide N-glycosidase F (PNGase F). Endo H removes high-mannose type N-glycans, which are
found on immature proteins in the ER, while PNGase F removes all types of N-linked glycans,
including those found on proteins that have moved through the Golgi to the cell surface. Treat-
ment with PNGase F caused CRUMBS2 from both Poglut1wsnp and wild-type samples to shift
to the same size (Fig 4A), confirming that the difference in migration is due to differences in
N-glycosylation. Endo H treatment increased the mobility of the CRUMBS2 protein from
Poglut1wsnp embryoid bodies, suggesting this protein was modified with high mannose type N-
glycans and was likely localized to the ER (Fig 4A). In contrast, Endo H had no effect on the
majority of CRUMBS2 from wild-type embryoid bodies, demonstrating that this protein had
moved through the Golgi to the surface. A smaller portion of the wild-type protein was sensi-
tive to Endo H, suggesting that a small pool of the wild-type protein was in the ER. These data
demonstrate that mutant protein was modified with Endo H-sensitive N-glycans, while the
majority of the wild-type protein was modified with complex-type N-glycans sensitive to only
PNGase F. The results strongly suggest that the CRUMBS2 protein in Poglut1wsnp mutants is
localized to the ER and that O-glucosylation of EGF repeats is required for CRUMBS2 trans-
port to the Golgi, where subsequent processing to complex type N-glycan structures occurs.
By immunostaining, CRUMBS2 was detected in the apical plasma membrane of the E8.5
wild-type neural plate and primitive streak (Fig 4B and 4C). In contrast, there was no
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detectable apical CRUMBS2 in the Poglut1wsnp neural epithelium or primitive streak (Fig 4D
and 4E), consistent with the biochemical finding that Crumbs2 was trapped in the ER when it
was not O-glycosylated by POGLUT1.
CRUMBS1 was localized to the Golgi in both wild type and Poglut1wsnp mutants at this
stage (S4A and S4B Fig), which suggested that trafficking of these two Crumbs proteins is dif-
ferentially regulated in this tissue and that CRUMBS2 is the relevant target of POGLUT1 in the
early mouse embryo.
Fig 4. POGLUT1 is required for cell-surface localization of CRUMBS2. (A) Western blot of V5-tagged CRUMBS2 expressed in WT or Poglut1wsnp (ws)
EBs after being subjected to PNGase F or Endo H digestions (Materials and Methods). EBs were differentiated for 5–6 days. Wild-type CRUMBS2 protein is
modified with N-glycans sensitive to PNGase F, whereas CRUMBS2 from Poglut1wsnp EBs is modified with Endo H-sensitive N-glycans, consistent with
trapping of the protein in the ER. (B-E) Immunolocalization of CRUMBS2 in transverse sections of E8.5 wild-type neural plate (B) and primitive streak (C).
CRUMBS2 in transverse sections of the E8.5 Poglut1wsnp neural plate (D) primitive streak (E) is not localized to the apical cell surface (up). Scale bars:
20 μm.
doi:10.1371/journal.pgen.1005551.g004
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The gastrulation phenotypes of Poglut1wsnp and Crumbs2 are
indistinguishable
To test whether the loss of cell-surface CRUMBS2 could account for the phenotype of Poglut1
mutant embryos, we compared the phenotypes of null alleles of the two genes using marker
analyses. Like Poglut1mutants, E8.5 Crumbs2mutants have much less paraxial mesoderm,
marked by expression ofMeox1, than wild type (Fig 5A). Both Poglut1wsnp and Crumbs2
mutants had a discontinuous midline, as marked by expression of Brachyury in axial meso-
derm (Fig 5B). Although cardiac mesoderm was specified in Crumbs2 and Poglut1mutants, as
assayed by Nkx2.5 expression, the E8.5 cardiac anlage was thinner and wider in the mutant
than in wild type (Fig 5C) and the heart fields failed to fuse and form a single heart tube in
both mutants. Despite these morphological similarities, the expression of a Notch target gene
in the somites, Uncx4.1, appeared normal in the paraxial mesoderm of Crumbs2mutants (S5
Fig), whereas it is not expressed in Poglut1wsnp embryos, confirming that the Notch pathway is
blocked by the absence of POGLUT1 but not the absence of CRUMBS2.
The most prominent phenotype of both Poglut1wsnp and Crumbs2mutants was the short-
ened body axis accompanied by a deficit of mesoderm. Mesoderm cells arise during gastrula-
tion in an epithelial-to-mesenchymal transition (EMT) at the primitive streak, in which cells
delaminate from the epithelial epiblast layer at the site of breakdown of the basement mem-
brane, down-regulate E-cadherin, acquire mesenchymal characteristics and begin to migrate
around the circumference of the embryo. The primitive streak regions of Poglut1wsnp and
Crumbs2mutants were comparable to wild-type at E7.5 (Fig 6A–6C). However, by E8.0 both
the mutants had a broader streak than wild type, marked by the region of basement membrane
breakdown at the streak (Fig 6D–6F). In both mutants, cells near the streak accumulated some
ectopic laminin (Fig 6E’ and 6F’). In both Poglut1wsnp and Crumbs2-/- embryos, cells expressing
E-cadherin accumulated at the primitive streak (Fig 6E” and 6F”), although some E-cadherin-
negative cells were present in thin mesodermal wings (Fig 6E” and 6F”). The decreased number
of mesoderm cells was apparent in laminin-stained transverse sections: in wild-type embryos,
anterior head mesenchyme was present below the neural epithelium (Fig 6D) but there was
very little anterior head mesenchyme present in both the mutants (asterisks in Fig 6E and 6F).
Discussion
Our data confirm previous findings in cultured cells and show that POGLUT1 is required for
mouse NOTCH1 activity in vivo, as it is in Drosophila. As in Drosophila, POGLUT1 is required
for the cleavage of NOTCH1 and activity of the Notch signaling pathway in vivo in the midges-
tation mouse embryo. The effects of POGLUT1 on Notch are apparent early in development:
activated NOTCH1 accumulates in cells of the nascent mesoderm immediately after they exit
the primitive streak, presumably setting the stage for segmentation of the presomitic mesoderm
[47]. In contrast, our data indicate that the earlier developmental phenotype of Poglut1
mutants is caused by the loss of glucose modification of another EGF repeat-containing pro-
tein, the apical transmembrane protein CRUMBS2.
Notch extracellular domain is decorated with O-fucose, as well as O-glucose, and loss of
mouse Pofut1 phenocopies Rbpjkmutants. CRUMBS2 and CRUMBS1 also have putative
POFUT1 consensus sites (11 and 9 sites, respectively) [11, 26, 48]. The stronger phenotype of
mouse Poglut1 than Pofut1mutants suggests that the two types of O-glycosylation have distinct
effects on the activities of CRUMBS proteins.
Previous studies that defined the activities of enzymes that glycosylate EGF repeats used
short fragments of proteins that contained a few EGF repeats expressed in cell lines [13, 21,
24]. In the experiments presented here, we showed that full-length CRUMBS2 protein is
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modified by addition of a glucose-xylose-xylose trisaccharide to EGF repeat 6 in vivo. Although
we assayed only a single repeat, we predict that most or all of the 8 EGF repeats of CRUMBS2
that include the consensus sequence for modification are likely to be O-glucosylated.
In the absence of O-glucose modification, CRUMBS2 is trapped in the ER and fails to accu-
mulate at the apical membrane of cells in the mouse embryo. This is different from the effect of
Poglut1mutants on NOTCH: in both Drosophila Rumimutants and mammalian Poglut1
knockdown cell lines, O-glucosylation is not required for cell surface localization or ligand
binding of NOTCH; instead, O-glucosylation is required for the proper conformation of
NOTCH to allow efficient cleavage by metalloproteases (S2 cleavage) and presenilin (S3
Fig 5. Indistinguishable phenotypes of early Poglut1wsnp andCrumbs2mutant embryos. (A)Meox1
expression is reduced and unsegmented in the paraxial mesoderm of both mutants at E8.5 (dorsal views). (B)
Brachyury expression at E8.5 shows a smaller primitive streak at the posterior end and a discontinuous
midline in both mutants (ventral view, anterior up). (C) Nkx2.5 expression shows the abnormal shape of the
heart fields in the mutants at E8.5, ventral views. Anterior is up in all panels. Scale bars: 150 μm.
doi:10.1371/journal.pgen.1005551.g005
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cleavage) to generate the active NICD transcription factor [13, 24]. As POGLUT1 localizes to
the endoplasmic reticulum, the lack of cell surface localization of CRUMBS2 in Poglut1
mutants is likely to be due to a requirement for glycosylation of the EGF repeats of CRUMBS2
Fig 6. Indistinguishable gastrulation defects in Poglut1wsnp andCrumbs2-/- embryos. (A-C) Transverse sections through the primitive streak of early
bud (E7.5) wild-type (A), Poglut1wsnp (B) andCrumbs2-/- (C) embryos immunostained for laminin (green) and E-Cadherin (red). The primitive streak (right) is
marked by the break in the laminin-containing basement membrane (vertical bar). The mesodermal wings between the two laminin-containing basement
membranes surround nearly the entire embryo in all three genotypes. (D-F) Transverse sections through E8.0 wild-type (D), Poglut1wsnp (E) andCrumbs2-/-
(F) embryos at E8.0 (D, E, F). By E8.0 the mutants have less mesoderm (compare the head mesenchyme in WT and mutants, asterisks). am = amnion. D’, E’
and F’ and D”, E” and F” are higher magnification of the primitive streak (boxed in D, E, F) showing laminin expression (D’, E’ and F’) and E-Cadherin
expression (D”, E” and F”). Both mutants have a broader streak as defined by the region of laminin breakdown. Both Poglut1wsnp andCrumbs2-/-mutants
show an accumulation of E-cadherin+ cells in the vicinity of the primitive streak. Scale bars: A to F = 20 μm and D’ to F” = 40 μm.
doi:10.1371/journal.pgen.1005551.g006
POGLUT1 Is Required for Activity of Mouse CRUMBS2
PLOSGenetics | DOI:10.1371/journal.pgen.1005551 October 23, 2015 12 / 21
for its correct folding in the ER and subsequent trafficking to the Golgi and the cell surface.
This hypothesis is supported by the accumulation of Endo H-sensitive forms of CRUMBS2 in
Poglut1wsnp mutant embryoid bodies.
The EGF repeats in Drosophila Crumbs can also be modified by Rumi/POGLUT1 [43].
However, a mutant form of Drosophila Crumbs in which alanine replaced serine in all seven
potential Rumi/POGLUT1 modification sites did not produce a mutant phenotype: homozy-
gous S-to-A mutants were viable and appeared normal, and most of the mutant Crumbs pro-
tein localized normally to the membrane [43]. Thus glucose modification of CRUMBS2 is
essential for its function in mammals but not in Drosophila. In Drosophila, Rumimutants
exhibit a Notch-dependent phenotype only when raised at higher temperatures [24, 43]. In
contrast, POGLUT1-dependent modifications are essential for the activity of mammalian
NOTCH. The more significant role of O-glucose addition in mammals may correlate with the
more extensive POGLUT1-dependent modifications present on the mammalian proteins and
may also reflect the higher body temperature of mammals. In all cases examined to date, O-glu-
cose is extended to the trisaccharide form on all the EGF repeats of mammalian NOTCH [13,
21] and CRUMBS2 (this work). However, the predominant species of POGLUT1-modified
EGF repeats in Drosophila Notch and Crumbs is glucose monosaccharide, which only occa-
sionally is extended to the trisaccharide [24, 43].
POGLUT1-dependent modification of CRUMBS2 proteins is likely to be important in a
variety of human diseases. Mutations in EGF repeats of human CRUMBS1, another likely sub-
strate of POGLUT1, are found in retinitis pigmentosa and Leber congenital amaurosis [49–52],
and could affect the glycosylation status of CRUMBS1 and its membrane localization in the
eye. Mutations in human CRUMBS2 are associated with some cases of congenital nephrosis
[53, 54], suggesting that POGLUT1 is also a candidate gene in this human syndrome. Whole
exome sequencing has demonstrated that human POGLUT1mutations are responsible for a
subset of the cases of Dowling-Degos Disease, an autosomal dominant hyperpigmentation dis-
order [55]. POGLUT1 is overexpressed in several human leukemia, breast cancer and endome-
trial cancer cell lines [28, 56–58]. It has been suggested that POGLUT1 mutations disrupt the
activation of Notch signaling pathway in these diseases; our results suggest that POGLUT1-de-
pendent Crumbs activity should also be considered.
Materials and Methods
Ethics statement
This work was approved by the Memorial Sloan Kettering Cancer Center IACUC (protocol
number 02-06-013) and studies were conducted in accordance to their guidelines.
Mouse strains
The wsnp allele was generated by ENUmutagenesis of C57/BL6J mice [33]. This allele harbors
a T to C transition in the splice donor site of intron 3 of Poglut1, which creates an SfaNI restric-
tion fragment length polymorphism. ES cells harboring the knock-out first allele were obtained
from the International Mouse Knockout Project (HEPD0700_1_A09). They were injected into
C57BL/6J blastocysts to generate chimeras, and chimeras were screened for transmission of
gene trap allele (Poglut1gt), which introduces the LacZ coding gene downstream of Exon 3. The
conditional allele (Poglut1flox) was generated by crossing Poglut1gt to actin-Flip mice [59]. The
null allele (Poglut1Δ) was generated by crossing conditional allele to CAG-Cre [60]. The condi-
tional allele of Crumbs2 [61] was crossed to CAG-Cre (Jax) to generate the null allele
(Crumbs2-/-). Crumbs1rd8 [62] and Sox2-Cre [38] have been described. Mice carrying the
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nodal-lacZ knock-in allele [63] was a gift from Elizabeth Robertson and the TOPGAL mice
[64] were provided by Elaine Fuchs.
Mapping and identification ofwsnp
The wsnpmutation was mapped to a 407 kb interval between D16Mit90 and D16Mit12 simple
sequence length polymorphism (SSLP) markers by meiotic recombination. Genomic DNA was
purified from three mutants pooled together, and exonic DNA across the genomic interval was
enriched using Agilent SureSelect solution based technology with custom target capture. Sam-
ples were multiplexed and bar-coded for SOLiD sequencing. Sequencing reads were aligned to
the C57BL/6 reference genome using SHRiMP [65].
Phenotypic analysis
Whole mount in situ hybridization and LacZ staining was performed as published [36]. For in
situ hybridization embryos were dissected in ice-cold PBS-0.4%BSA and fixed in 4% parafor-
maldehyde overnight. Following a series of dehydration and rehydration in methanol series,
embryos were hybridized with the corresponding in situ probes, washed and developed using
BM-purple. For β-galactosidase activity, embryos were dissected in ice cold PBS and fixed in
freshly prepared fixative solution (5mM EGTA, 0.2% glutaraldehyde and 2mMMgCl2 in 0.1M
phosphate buffer (pH 7.3)) for 10–15 minutes. Following washes in detergent rinse (2mM
MgCl2, 0.02% Nonidet P-40 and 0.01% sodium deoxycholate in 0.1M phosphate buffer), the
embryos were stained with X-GAL (1mg/ml X-GAL, 5 mM potassium ferricyanide) in deter-
gent rinse) overnight. Following staining, the embryos were rinsed in PBS and fixed in 4%PFA
for an hour before imaging.
Immunostaining
Embryos were dissected in ice cold PBS-BSA and fixed in 4% PFA for one hour at room tem-
perature for immunostaining or over-night at 4°C for in-situ hybridization. The embryos were
embedded in OCT (optimal cutting temperature) and cryosectioned at 10–12 μm thickness.
Immunostaining on frozen sections was performed as published [36]. Primary antibodies were
diluted in blocking buffer and incubated overnight at 4°C. The secondary antibodies were
diluted in blocking buffer and incubated for 1 hour at room temperature. DAPI was included
in the secondary incubation.
For whole mount active NOTCH1 immunostaining, embryos were dissected in ice cold
PBS-BSA and fixed overnight in 4% PFA/PBS at 4°C, dehydrated in methanol and stored at
-20°C overnight. Following rehydration, antigen unmasking was performed in Vector unmask-
ing solution (H-3300 Vector labs) at 98°C for 10 minutes. After reaching room temperature
embryos were washed in MilliQ water and incubated in acetone at -20°C for 8 minutes. Next
the embryos were washed and incubated in blocking buffer overnight at 4°C (Blocking
buffer = 10% goat serum, 5% BSA, 0.3% Triton-X100 in PBS). The embryos were incubated in
anti-cleaved NOTCH1 antibody (1:1000) for 2 days. Following 4–5 washes with blocking
buffer, the embryos were incubated in secondary antibody overnight at 4°C. The embryos were
washed extensively before mounting in glass-bottom dishes for confocal imaging.
The following antibodies were used: anti-CRUMBS1 and anti-CRUMBS2 were obtained
from Jane McGlade (Hospital for Sick Children, Toronto) and were used at 1:100 and 1:50
respectively [66]; Anti-pan-CRUMBS was a kind gift from Ben Margolis (University of Michi-
gan, Ann Arbor) and was used at 1:200 [67]. Commercially available antibodies used were:
anti-SOX2 (Santa Cruz 1:100), anti-E-CADHERIN (Sigma 1:200), anti-LAMININ (Sigma
1:200) and anti-active NOTCH1 (Val 1744—Cell Signaling 1:1000). Confocal microscopy was
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performed using a Leica-Inverted SP5 or Leica-Upright SP5 laser, point-scanning confocal
microscope. Confocal datasets were analyzed using the Volocity software package
(Improvision).
Western blot analysis
Embryos were dissected in ice cold PBS and snap frozen on dry ice. The embryos were lysed in
RIPA buffer with protease inhibitor added. The lysates were equilibrated on ice for 20 minutes,
after which they were sonicated (3 X 30 seconds). Lysates were incubated for 10 minutes in ice
and then centrifuged to remove the cell debris. The supernatant was mixed with 2X SDS load-
ing dye (1:1) and loaded on an SDS-PAGE for analysis. The dilutions for primary antibody
were: anti-pan-CRUMBS (Ben Margolis [64], 1:2000), anti-Cleaved-NOTCH1 (Val 1744—Cell
Signaling 1:1000), anti-NOTCH1 (Abcam 1:1000) and anti-V5 (Invitrogen 1:5000).
Cloning of tagged CRUMBS2
The Crumbs2 cDNA was synthesized from wild-type embryos harvested at E8.5. Full-length
Crumbs2 was cloned into the Gateway vector pDEST40 to generate Crumbs2 with His and V5
tags at its C-terminal. This sequence was sub-cloned with the tags into the EcoR1 site of the
pCAGGS vector to generate pCAGGS-Crumbs2 for high expression in embryonic stem cells.
Generation of ES cell lines expressing full-length tagged CRUMBS2
ES cells were derived using the 2i protocol from both wild type and Poglut1wsnp blastocysts
[44], were eventually weaned off iMEFs and were cultured in KnockOut DMEM (Gibco) sup-
plemented with 15% fetal bovine serum (HyClone), 2 mM L-glutamine (Gibco), 0.1 mM β-
mercaptoethanol (Gibco), 0.1 mM non-essential amino acids (Gibco), 1 mM sodium pyruvate
(Gibco), 1% v/v penicillin and streptomycin (Gibco), 1,000 units LIF (Millipore), 1 μM
PD0325901 and 3 μMCHIR99021 (Stemgent). To generate stable cells lines expressing tagged
full-length CRUMBS2, wild-type and Poglut1wsnp ES cells were electroporated with pCAGGS-
Crumbs2 DNA linearized by cutting with ScaI and a circular PGK-Puro-pA plasmid [68] that
confers a transient puromycin resistance. Stable lines were selected with puromycin (Invitro-
gen) using published protocols [69]. Fifteen independent colonies were screened for expression
of tagged full length CRUMBS2 both by immunofluorescence and western blots analysis with
the anti-V5 antibody. One cell line each for wild type and Poglut1wsnp was selected based on
high expression levels and was used for protein purification.
Embryoid body (EB) differentiation
ES cells were trypsinized and re-suspended at 106 ES cells per 10 ml media in non-adherent
conditions (10 cm bacterial petri dishes (VWR) coated with Sigmacote). EBs were cultured in
the absence of LIF and 2i in DMEMmedium containing 15% fetal bovine serum, 2 mM L-glu-
tamine (Gibco), 0.1 mM β-mercaptoethanol (Gibco), 0.1 mM non-essential amino acids
(Gibco), 1 mM sodium pyruvate (Gibco), 1% v/v penicillin and streptomycin (Gibco). The
medium was replaced every day. To determine the time course of endogenous CRUMBS2
expression, EBs were harvested daily from day 1 to day 6.
Purification of CRUMBS2 protein
ES cells were cultured in large (6X15 cm) plates and differentiated to embryoid bodies. Wild-
type and Poglut1wsnp mutant embryoid bodies were harvested 2 days after induction of differ-
entiation from ES cells and snap frozen. These were re-suspended in RIPA buffer with 2%
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DDM (n-Dodecyl β-D-maltoside) and Roche protease inhibitor and subjected to three cycles
of freeze-thaw to increase the release of membrane protein, then sonicated for 4 times for 30
seconds each and incubated at 4°C for one hour with continuous shaking. The lysates were
clarified by centrifugation for 20 minutes at 15,520 g. The supernatant was incubated with
anti-V5 antibody (1:1000) for 4 hours at 4°C shaking. This mixture was incubated with mag-
netic nickel beads (Invitrogen) for 2 hours at 4°C shaking. The beads were rinsed four times in
RIPA lysis buffer, and the beads were heated to 95°C in 2XSDS loading buffer to elute the pro-
tein. The eluted protein was run on a 7% SDS-PAGE. The gel was washed 3 times in HPLC
purified water and then stained with Pierce gel code blue stain reagent for 5–10 minutes. Fol-
lowing staining, the bands were cut out, subjected to chymotrypsin digest and used for mass
spectrometric analysis.
Cleavage of N-glycans by PNGase F and Endo H
After 5 days of differentiation, wild-type and Poglut1wsnp EBs were lysed in sample buffer con-
taining SDS and β-mercaptoethanol, and denatured by boiling for 5 min. After cooling, NP-40
was added and samples were diluted in PBS to final concentrations of 1% NP-40,<1%SDS and
1% β-mercaptoethanol. Samples were then incubated with 5U of Peptide-N-Glycosidase F
(PNGase F), prepared as described [70] or 25mU of Endoglycosidase H (Endo H) (Roche)
overnight at 37°C. Western blotting was performed to detect the removal of N-glycans from
V5-tagged CRUMBS2 protein.
Mass spectrometric analysis
Bands containing purified mouse CRUMBS2-V5 were reduced, alkylated, and subjected to in-
gel chymotryptic digest as described previously [45]. Peptides were analyzed by nanoLC-MS/
MS as previously described [21]. Glycosylation of peptides was identified by using neutral loss
searches, and Extracted Ion Chromatograms (EICs) were generated to compare relative
amounts of each glycoform of the relevant peptides.
Supporting Information
S1 Fig. Nodal and Wnt signaling at the streak are normal in Poglut1wsnpmutants. Both
Nodal-lacZ expression (A) andWnt reporter activity (TOPGAL) (B) are on the posterior side
of E7.5 Poglut1wsnp embryos, as in wild type, although the length of the streak is shorter along
the proximal-distal axis than in wild type. Lateral views, anterior to the left, distal down. Scale
bars: 150 μm.
(TIF)
S2 Fig. Poglut1 is broadly expressed in the early embryo and is required in the epiblast. (A)
Ubiquitous expression of Poglut1 in the epiblast-derived tissues from E6.5 to E8.5, visualized
by β-galactosidase activity in Poglut1gt/+ embryos; lateral views, anterior left. (B) Trans-hetero-
zygous Poglut1wsnp/gt embryos arrest at approximately E8.5 with the same morphology seen in
wsnp homozygotes. (C)Meox1 expression in wild type and Poglut1 epiblast-deleted embryos at
E8.5. Poglut1 epiblast-deleted embryos have less paraxial mesoderm than wild type and are
indistinguishable from Poglut1wsnp and Poglut1-/- embryos. (B, C) Dorsal views; anterior up.
Scale bars: 150 μm.
(TIF)
S3 Fig. EGF repeat 6 of mouse CRUMBS2 is O-glucosylated in wild-type EBs but not in
Poglut1wsnp EBs. (A) Western blot of V5-tagged full-length CRUMBS2 extracted fromWT
and Poglut1wsnp ES cells differentiated to EBs, probed with anti-V5 antibody, showing the more
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rapid migration of tagged CRUMBS2 in Poglut1wsnp embryoid bodies compared to the protein
from wild-type EBs. (B) Chymotryptic peptides from full-length CRUMBS2 purified fromWT
EBs were analyzed by mass spectrometry as described in Methods. The top panel shows a full
MS spectrum of ions eluting at 4.9 minutes. The ion labeled [M+3H]3+ (m/z 1048.0) matches
the mass for the triply charged form of the peptide 258SGERCEVDEDECASGPCQNGGQ
CL281 from EGF repeat 6 modified with a glucose trisaccharide. CID fragmentation of the ion
generates the MS2 spectra in the bottom panel, which reveals sequential neutral losses of the
two xyloses and glucose from the glycopeptide. Several fragment ions (b- or y-ions) of peptide
are shown confirming its identity. (C) Chymotryptic peptides from full-length Crumbs2 puri-
fied from Poglut1wsnp EBs were analyzed as in B. The top panel shows a full MS spectrum of
ions eluting at 5.0 minutes. The ion labeled [M+3H]3+ (m/z 905.9) matches the mass for the
triply charged form of the same peptide from EGF repeat 6 with no modification. CID frag-
mentation of the ion generates the MS2 spectra in the bottom panel. Several fragment ions
(b- or y-ions) of the peptide are shown that confirm the identity of the peptide. Glucose is rep-
resented by a blue circle and xylose is represented as a yellow star, and the peptide by a black
line. Red diamonds in MS spectra indicate ions chosen for CID fragmentation, and blue dia-
monds indicate the location of the parent ion fragmented in the MS2 spectra. The blue under-
lined S in the peptide sequence indicates the serine residue of the consensus sequence for O-
glucosylation.
(TIF)
S4 Fig. CRUMBS1 is localized to the Golgi in the early embryo. (A) Immunostaining for
CRUMBS1 (green) in transverse sections through the primitive streak of wild-type and
Poglut1wsnp embryos at E8.5. (B) The same image as in (A), including the red channel that
shows the localization of GM130. CRUMBS1 is localized to the Golgi, as judged by its colocali-
zation with GM130. CRUMBS1 localization is not altered in Poglut1wsnp mutants at this stage.
Scale bars: 40 μm.
(TIF)
S5 Fig. NOTCH1 is active in Crumbs2mutants. (A) Western blots for cleaved NOTCH1 in
lysates from E8.5 wild-type, Poglut1wsnp and Crumbs2 embryos. Cleaved NOTCH1 was
reduced in Poglut1wsnp mutants, but unaltered in Crumbs2mutants. (B) Uncx4.1 at E8.5 is
expressed in the caudal half of each somite in wild type, but is undetectable in Poglut1wsnp
mutants (n = 3). In contrast, Uncx4.1 is expressed in a striped pattern in Crumbs2mutants
(n = 3). Dorsal view, anterior up. Scale bar: 150 μm.
(TIF)
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